EyeHealthIntel / Market opportunity

    The market is not
    “people who need
    an eye app.”

    It is the infrastructure between billions of eyes and the systems that care for them.

    EyeHealthIntel sits at the intersection of global eye health, consumer health records, telehealth, smartphone imaging, medical AI, clinical workflow and research infrastructure.

    01

    Human need

    Start with the people,
    not the TAM.

    2.2B+

    people live with near or distance vision impairment.

    1B+

    cases are estimated to be preventable or still unaddressed.

    Source: World Health Organization, World report on vision.

    2.2 billion people are not EyeHealthIntel's TAM. They describe the scale of the underlying human problem.
    01

    Human need

    People who could benefit from better access, continuity or eye-health information.

    02

    Addressable workflows

    Consumer health, telehealth, optometry, ophthalmology, pharmacies, primary care, research and health systems.

    03

    Commercial market

    Subscriptions, SDK/API usage, enterprise licensing, partner deployments and research infrastructure.

    02

    Why now

    Five curves are
    converging.

    01

    Camera capability

    Macro photography, autofocus and computational imaging continue improving.

    02

    AI infrastructure

    Visual models can increasingly work with structured imaging inputs — but input quality remains fundamental.

    03

    Telehealth

    Healthcare increasingly happens outside specialist facilities.

    04

    Consumer health records

    Users increasingly expect health information to persist over time.

    05

    Regulatory maturity

    Medical AI is moving toward explicit governance, provenance, monitoring and lifecycle control.

    EyeHealthIntel is designed at the intersection of these five curves.

    03

    One infrastructure, several markets

    Consumer

    Personal longitudinal Eye Record

    Telehealth

    Guided patient capture

    Opticians

    Structured remote / follow-up imaging

    Health systems

    Workflow and longitudinal infrastructure

    Research

    Consented structured datasets

    API / SDK

    Embedded capture and quality infrastructure

    OEM

    Camera / device integration

    04

    Major-market opportunity

    The product can be global.
    The release cannot be generic.

    01

    Europe

    GDPR + MDR + EU AI Act-aware architecture

    02

    United States

    FDA pathway + QMSR + partner-specific privacy assessment

    03

    Nordics

    Digitally mature healthcare and telehealth ecosystems

    04

    India

    Scale, smartphone distribution and uneven specialist access

    05

    Latin America

    Mobile-first healthcare opportunity and fragmented specialist access

    06

    Africa

    Potential reach where traditional specialist infrastructure is limited

    07

    Asia

    Massive mobile population + rapidly evolving digital-health systems

    Each jurisdiction receives its own validation, regulatory and release gate.

    No global “switch” can activate clinical functionality everywhere.

    05

    The economic architecture

    Value can be created
    at more than one layer.

    01

    Consumer

    Premium longitudinal records, reporting and family services

    02

    Healthcare SaaS

    Platform + accepted workflow economics

    03

    SDK / API

    Usage and enterprise licensing

    04

    Research

    Consented infrastructure and study collaborations

    05

    OEM / White label

    Embedded imaging infrastructure

    Consumer distribution can create reach and device intelligence.

    Healthcare integrations can create workflow value.

    Longitudinal records can create a differentiated data architecture.

    06

    The network effect

    Every new device
    teaches the system about devices.

    Every new population
    improves the validation question.

    Every new longitudinal record
    adds time.

    These effects only compound under explicit consent, governance and jurisdiction-specific validation. Without them, no data enters the learning loop.

    01

    Device intelligence

    Which cameras can reliably capture what?

    02

    Quality intelligence

    Under which conditions is an image usable?

    03

    Population validation

    How does performance differ across populations?

    04

    Longitudinal intelligence

    What does change look like over time?

    07

    Market scenarios

    Explore scale.

    Result

    1.0M

    longitudinal users

    Illustrative scenario · not a forecast

    Request detailed market model →
    08

    The Ravolution thesis

    Why this belongs
    at Ravolution.

    01

    Find the friction

    Eye information is episodic, fragmented and difficult to compare.

    02

    Invent the mechanism

    Device-adaptive capture + quality gates + longitudinal records.

    03

    Protect the core

    Patent-pending imaging and normalization architecture.

    04

    Build and prove

    Consumer system + governed clinical infrastructure.

    05

    Scale the system

    Consumers · healthcare · API · research · OEM.

    EyeHealthIntel represents the Ravolution thesis in its purest form: identify infrastructure that should exist, build it before the category is obvious, and create several paths through which it can reach global scale.